Emergent BioSolutions Inc. - Common Stock (EBS)
CUSIP: 29089Q105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,021,849
- Total 13F shares
- 36,048,259
- Share change
- +948,451
- Total reported value
- $229,963,501
- Put/Call ratio
- 52%
- Price per share
- $6.38
- Number of holders
- 159
- Value change
- +$8,627,423
- Number of buys
- 90
- Number of sells
- 80
Quarterly Holders Quick Answers
What is CUSIP 29089Q105?
CUSIP 29089Q105 identifies EBS - Emergent BioSolutions Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29089Q105:
Top shareholders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
7.3%
|
3,977,535
|
$25,376,673 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
3,214,003
|
$15,620,055 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
4.8%
|
2,502,488
|
$12,162,092 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
4.4%
|
2,297,621
|
$11,166,438 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
1,710,749
|
$8,314,240 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.1%
|
1,596,637
|
$7,758,113 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.2%
|
1,157,862
|
$5,627,210 | — | 31 Mar 2025 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2.2%
|
1,141,589
|
$5,548,123 | — | 31 Mar 2025 | |
| OAK HILL ADVISORS LP |
13F
|
Company |
2.1%
|
1,113,338
|
$5,410,823 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.1%
|
1,090,655
|
$5,300,584 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
2.1%
|
1,087,343
|
$5,284,487 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.8%
|
931,627
|
$4,527,707 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
866,467
|
$4,211,034 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.6%
|
849,373
|
$4,127,953 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
833,316
|
$4,048,000 | — | 31 Mar 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1.6%
|
831,191
|
$4,040,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
760,247
|
$3,694,800 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
747,959
|
$3,635,081 | — | 31 Mar 2025 | |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.2%
|
627,671
|
$3,050,481 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
612,290
|
$2,977,129 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
583,271
|
$2,834,697 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.1%
|
579,396
|
$2,815,864 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1%
|
545,567
|
$2,651,456 | — | 31 Mar 2025 | |
| Fuad El-Hibri |
3/4/5
|
Director |
—
class O/S missing
|
1,343,405
|
$2,444,997 | — | 03 Dec 2021 | |
| Trexquant Investment LP |
13F
|
Company |
0.86%
|
449,621
|
$2,185,158 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.79%
|
412,700
|
$2,005,722 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.76%
|
396,800
|
$1,928,448 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.72%
|
375,034
|
$1,822,665 | — | 31 Mar 2025 | |
| Values First Advisors, Inc. |
13F
|
Company |
0.72%
|
375,247
|
$1,814,849 | — | 31 Mar 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.68%
|
356,281
|
$1,731,523 | — | 31 Mar 2025 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.64%
|
335,429
|
$1,630,185 | — | 31 Mar 2025 | |
| Jennifer Lynne Fox |
3/4/5
|
EVP, Ext Aff, GC, Corp Sec |
—
mixed-class rows
|
409,551
mixed-class rows
|
$1,515,286 | — | 11 Jul 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.57%
|
294,916
|
$1,433,291 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.54%
|
279,141
|
$1,356,625 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.53%
|
275,716
|
$1,339,000 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.52%
|
272,274
|
$1,323,252 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.44%
|
227,936
|
$1,107,769 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.41%
|
213,861
|
$1,039,362 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
213,747
|
$1,038,810 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.38%
|
196,384
|
$954,426 | — | 31 Mar 2025 | |
| Robert Kramer |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
1,041,110
mixed-class rows
|
$921,027 | — | 09 Jun 2023 | |
| Morse Asset Management, Inc |
13F
|
Company |
0.36%
|
187,464
|
$911,075 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.31%
|
163,463
|
$794,432 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.31%
|
158,685
|
$771,209 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
148,802
|
$723,178 | — | 31 Mar 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.28%
|
147,480
|
$716,753 | — | 31 Mar 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.28%
|
146,700
|
$712,962 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.27%
|
142,966
|
$694,815 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.27%
|
138,669
|
$673,931 | — | 31 Mar 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.26%
|
136,333
|
$662,578 | — | 31 Mar 2025 |
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2025
As of 30 Jun 2025,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,048,259 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, AMERICAN CENTURY COMPANIES INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, PALISADE CAPITAL MANAGEMENT, LP, MARSHALL WACE, LLP, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
159
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
158
Q2 2025 holders
159
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.